Market
Indoco Remedies receives EIR from USFDA for Goa facility, shares jump 5%
Updated : November 25, 2019 09:32 AM IST
Indoco shares advanced as much as 5.4 percent to Rs 157.55 per share intraday on the BSE.
The inspection was carried out between October 7 to 15 and was classified as VAI (Voluntary Action Indicated) by the USFDA.


Have you signed up for Primo, our daily newsletter?
It has all the stories and data on the market, business, economy and tech that you need to know.

To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more